S303: EFFECT OF PEGCETACOPLAN ON QUALITY OF LIFE IN COMPLEMENT-INHIBITOR NAÏVE PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: RESULTS FROM THE PHASE 3 PRINCE STUDY

• D. Gomez-Almaguer,
• R. Wong,
• T. Dumagay,
• M. Al-Adhami,
• J. Savage,
• Z. Hakimi,
• A. Bogdanovic

Affiliations

D. Gomez-Almaguer

1 Hematology Service, Hospital Universitario “Dr José Eleuterio González,” Universidad Autónoma de Nuevo León, Monterrey, Mexico

R. Wong

2 Sir Y.K. Pao Centre for Cancer & Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Sha Tin, Hong Kong

T. Dumagay

3 Department of Cellular Therapeutics, Makati Medical Centre, Makati, Philippines

M. Al-Adhami

4 Apellis Pharmaceuticals, Inc., Waltham, United States of America

J. Savage

4 Apellis Pharmaceuticals, Inc., Waltham, United States of America

Z. Hakimi

5 Swedish Orphan Biovitrum AB, Stockholm, Sweden

A. Bogdanovic

6 Clinic of Hematology, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia